Abpro Bio (A195990) Stock Overview
Manufactures and sells machine tools in South Korea and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
A195990 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Abpro Bio Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩1,400.00 |
| 52 Week High | ₩4,470.00 |
| 52 Week Low | ₩992.00 |
| Beta | -0.050 |
| 1 Month Change | -36.94% |
| 3 Month Change | -25.53% |
| 1 Year Change | -54.69% |
| 3 Year Change | -76.90% |
| 5 Year Change | -88.93% |
| Change since IPO | -96.61% |
Recent News & Updates
Recent updates
Abpro Bio Co., Ltd.'s (KOSDAQ:195990) Popularity With Investors Under Threat As Stock Sinks 31%
Jan 06
Abpro Bio Co., Ltd.'s (KOSDAQ:195990) 27% Price Boost Is Out Of Tune With Revenues
Nov 05Would Abpro Bio (KOSDAQ:195990) Be Better Off With Less Debt?
Nov 03Abpro Bio Co., Ltd.'s (KOSDAQ:195990) Popularity With Investors Under Threat As Stock Sinks 27%
Aug 18Abpro Bio (KOSDAQ:195990) Is Making Moderate Use Of Debt
Jul 25Abpro Bio Co., Ltd.'s (KOSDAQ:195990) Share Price Could Signal Some Risk
Mar 12Abpro Bio Co., Ltd. (KOSDAQ:195990) Shares May Have Slumped 29% But Getting In Cheap Is Still Unlikely
Dec 06We Think Abpro Bio (KOSDAQ:195990) Has A Fair Chunk Of Debt
Oct 21Getting In Cheap On Abpro Bio Co., Ltd. (KOSDAQ:195990) Is Unlikely
Jul 12Revenues Not Telling The Story For Abpro Bio Co., Ltd. (KOSDAQ:195990)
Mar 14Is Abpro Bio (KOSDAQ:195990) Using Debt In A Risky Way?
Apr 05Abpro Bio (KOSDAQ:195990) Shareholders Booked A 92% Gain In The Last Year
Feb 02Shareholder Returns
| A195990 | KR Machinery | KR Market | |
|---|---|---|---|
| 7D | 0.7% | 4.8% | 7.8% |
| 1Y | -54.7% | 64.7% | 140.7% |
Return vs Industry: A195990 underperformed the KR Machinery industry which returned 64.7% over the past year.
Return vs Market: A195990 underperformed the KR Market which returned 140.7% over the past year.
Price Volatility
| A195990 volatility | |
|---|---|
| A195990 Average Weekly Movement | 21.3% |
| Machinery Industry Average Movement | 10.4% |
| Market Average Movement | 9.2% |
| 10% most volatile stocks in KR Market | 16.3% |
| 10% least volatile stocks in KR Market | 4.6% |
Stable Share Price: A195990's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: A195990's weekly volatility has increased from 14% to 21% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 45 | Lee Jae-yong | www.abprobio.co.kr |
Abpro Bio Co., Ltd. manufactures and sells machine tools in South Korea and internationally. It offers tapping centers, spindle machines, machining and turning centers, and machining centers with long table. The company was founded in 1991 and is headquartered in Daegu, South Korea.
Abpro Bio Co., Ltd. Fundamentals Summary
| A195990 fundamental statistics | |
|---|---|
| Market cap | ₩45.80b |
| Earnings (TTM) | -₩48.92b |
| Revenue (TTM) | ₩31.92b |
Is A195990 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A195990 income statement (TTM) | |
|---|---|
| Revenue | ₩31.92b |
| Cost of Revenue | ₩28.41b |
| Gross Profit | ₩3.51b |
| Other Expenses | ₩52.43b |
| Earnings | -₩48.92b |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.50k |
| Gross Margin | 11.00% |
| Net Profit Margin | -153.24% |
| Debt/Equity Ratio | 27.1% |
How did A195990 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/17 11:34 |
| End of Day Share Price | 2026/04/17 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Abpro Bio Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.